Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305 · cited 1×
“antigen uptake is less well recorded and depends on the type of polymer used [ 4 ].”
MethodSelf-citationPEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331 · cited 5×
“After incubation for 60 min at 37 °C the amount of particles in the acceptor compartment was determined using flow cytometry (FACScalibur, Becton Dickinson) [5, 8 ,17].”
BackgroundMethodInfluentialSelf-citationExpression of specific markers and particle transport in a new human intestinal M-cell model
Gullberg, E., Leonard, M., Karlsson, J., Hopkins, A. M., Brayden, D., Baird, A. W., & Artursson, P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4038 · Cited by 270
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting
Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224
The role of M cells in mucosal immunity
Hathaway, L. J., & Kraehenbuhl*, J.-P. (2000) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000693 · Cited by 131 · cited 1×
“The ability of M-cells to transport particulate structures is well established [33] and increasing the M-cell uptake has become an attractive strategy to improve current mucosal vaccines [34–36].”
BackgroundLuzardo-Alvarez, A., Blarer, N., Peter, K., Romero, J. F., Reymond, C., Corradin, G., & Gander, B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.015 · Cited by 59
Roth-Walter, F., Bohle, B., Schöll, I., Untersmayr, E., Scheiner, O., Boltz-Nitulescu, G., Gabor, F., Brayden, D. J., & Jensen-Jarolim, E. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.03.020 · Cited by 42 · cited 1×
“The ability of M-cells to transport particulate structures is well established [33] and increasing the M-cell uptake has become an attractive strategy to improve current mucosal vaccines [34–36].”
Background
Cited by
Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0073-2 · Cited by 1,885
“N-trimethyl chitosan (TMC) with a degree of quaternization of 15% was prepared from chitosan and used to make TMC nanoparticles, as described in the literature (17).”
MethodSelf-citationChitosan-based drug delivery systems
Bernkop-Schnürch, A., & Dünnhaupt, S. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.007 · Cited by 991
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
DNA Vaccines—How Far From Clinical Use?
Hobernik, D., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113605 · Cited by 457
Molecular Interaction of Proteins and Peptides with Nanoparticles
Shemetov, A. A., Nabiev, I., & Sukhanova, A. (2012) · ACS Nano · doi:10.1021/nn300415x · Cited by 432
Chitosan-based drug nanocarriers: Where do we stand?
Garcia-Fuentes, M., & Alonso, M. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.017 · Cited by 353
Fate of polymeric nanocarriers for oral drug delivery
Plapied, L., Duhem, N., des Rieux, A., & Préat, V. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.12.005 · Cited by 320
Self-citationAdvances in transcutaneous vaccine delivery: Do all ways lead to Rome?
Bal, S. M., Ding, Z., van Riet, E., Jiskoot, W., & Bouwstra, J. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.018 · Cited by 199
Self-citationN,N,N-Trimethyl chitosan: An advanced polymer with myriad of opportunities in nanomedicine
Kulkarni, A. D., Patel, H. M., Surana, S. J., Vanjari, Y. H., Belgamwar, V. S., & Pardeshi, C. V. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.10.041 · Cited by 166
Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies
Coco, R., Plapied, L., Pourcelle, V., Jérôme, C., Brayden, D. J., Schneider, Y.-J., & Préat, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.017 · Cited by 162
Self-citationClaudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A., & Lo, D. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.033 · Cited by 137
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery
Cu, Y., Booth, C. J., & Saltzman, W. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.036 · Cited by 129
“This enhanced transport likely imparts higher efficacy for formulations carrying payload, as reported in recent studies using particles containing Hepatitis B antigen for intranasal [28] or OVA for oral [29] immunizations, where charge-neutral particles induced better immune responses over treatments with charged part…”
BackgroundFeng, G., Jiang, Q., Xia, M., Lu, Y., Qiu, W., Zhao, D., Lu, L., Peng, G., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061135 · Cited by 108
“Additionally, chitosan nanoparticles (nano-chitosan) possess lower cytotoxicity and more stability [17,18,19,20,21].”
BackgroundRetractedCarbohydrate Immune Adjuvants in Subunit Vaccines
Bashiri, S., Koirala, P., Toth, I., & Skwarczynski, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100965 · Cited by 45
Reviewing the biological activity of chitosan in the mucosa: Focus on intestinal immunity
Moine, L., Canali, M. M., Porporatto, C., & Correa, S. G. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.098 · Cited by 28
Metadata
- Authors
- Slütter, B., Plapied, L., Fievez, V., Alonso Sande, M., des Rieux, A., Schneider, Y.-J., Van Riet, E., Jiskoot, W., & Préat, V.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 138
- Issue
- 2
- Pages
- 113-121
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2157873907
- Cited by
- 192
- References
- 7
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.